Gaya takes a look at how our similarities and differences in music can bring us together ...

During the fourth quarter of 2025, the Fund returned 13.10% (Institutional Shares), outperforming the Russell 3000 Index ...

As enterprises shift from a “cloud-first” to what some describe as an “AI-first” infrastructure era, many are discovering ...

Because if the office siren trend is too satirical, and traditional corporate dress too rigid, where does that leave the ...

Fourth-quarter and full-year 2025 Rezdiffra® (resmetirom) net sales of $321.1 million and $958.4 million, respectively As of year-end 2025, more ...

This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...

For generations, wise aunties and grandmothers have advised that the quickest path to the heart is through the stomach. Our elders also encourage us to trust our guts when it comes to matters of the ...

Merck & Co.’s presence in cancer has long rotated around its crown jewel checkpoint inhibitor Keytruda. But with the ...

In a collaboration between several labs at UNC Lineberger, researchers have defined cancer-associated fibroblast (CAF) ...

This is according to Jerold Mande, a nutrition expert who happens to be my shopping companion for the day. That a snack food ...

Today, I'll provide an update on the Rezdiffra launch, where we ended our first full year on the market at nearly $1 billion ...